Bruker Corp (BRKR): Total Liabilities
$3.73B
As of 2025-12-31
+14.6%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $3.73B | -6.5% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $3.99B | +40.7% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $2.84B | +14.4% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $2.48B | n/a | 2024-02-29, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Bruker Corp (BRKR) | 2025-12-31 | $3.73B | -6.5% |
| Waters Corp (WAT) | 2025-12-31 | $2.52B | -7.7% |
| Mettler Toledo International Inc (MTD) | 2025-12-31 | $3.74B | +11.0% |
| Revvity, Inc. (RVTY) | 2025-12-28 | $4.92B | +4.1% |
| Bio-Rad Laboratories, Inc. (BIO) | 2025-12-31 | $3.12B | +11.7% |
| Avantor, Inc. (AVTR) | 2025-12-31 | $6.23B | +1.2% |
| Agilent Technologies, Inc. (A) | 2025-10-31 | $5.99B | +0.6% |
| 10x Genomics, Inc. (TXG) | 2025-12-31 | $245.04M | +17.5% |
| Cytek Biosciences, Inc. (CTKB) | 2025-12-31 | $119.80M | +15.5% |
Compare BRKR, WAT, MTD, RVTY side by side · Screen every company in Laboratory Analytical Instruments ↗